Earlier investigations have shown that GLP-1 (Glucagon-like Peptide-1) analogs exhibit neuroprotective qualities in various models of neurological diseases, encompassing conditions such as Alzheimers disease, Parkinsons disease, and stroke
The difference is the target
[DOI] [PMC free article] [PubMed] [Google Scholar] 149.Chen J., Berry M.J
By triggering growth hormone release without meaningfully affecting cortisol or prolactin, it sidesteps many of the hormonal side effects that can complicate research
A high-quality BB10 peptide product should be clearly labeled, properly sealed, and supported by purity testing where available
Small-molecule neuroprotective compounds (J-147, 9-Me-BC): studied for mitochondrial and neurotrophic signalling outside the peptide class